Eye Veterinary Clinic Limited 09364585 false 2022-04-01 2023-03-31 2023-03-31 The principal activity of the company is that of a veterinary ophthalmology referral practice. Digita Accounts Production Advanced 6.30.9574.0 true true 09364585 2022-04-01 2023-03-31 09364585 2023-03-31 09364585 bus:Director1 1 2023-03-31 09364585 bus:Director2 1 2023-03-31 09364585 bus:Director3 1 2023-03-31 09364585 bus:OrdinaryShareClass1 bus:CumulativeShares 2023-03-31 09364585 bus:OrdinaryShareClass2 bus:CumulativeShares 2023-03-31 09364585 bus:OrdinaryShareClass3 bus:CumulativeShares 2023-03-31 09364585 bus:OrdinaryShareClass4 bus:CumulativeShares 2023-03-31 09364585 core:AcceleratedTaxDepreciationDeferredTax 2023-03-31 09364585 core:OtherDeferredTax 2023-03-31 09364585 core:CapitalRedemptionReserve 2023-03-31 09364585 core:RetainedEarningsAccumulatedLosses 2023-03-31 09364585 core:ShareCapital 2023-03-31 09364585 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 09364585 core:Goodwill 2023-03-31 09364585 core:FurnitureFittings 2023-03-31 09364585 core:OfficeEquipment 2023-03-31 09364585 core:PlantMachinery 2023-03-31 09364585 bus:SmallEntities 2022-04-01 2023-03-31 09364585 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 09364585 bus:FullAccounts 2022-04-01 2023-03-31 09364585 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 09364585 bus:RegisteredOffice 2022-04-01 2023-03-31 09364585 bus:Director1 2022-04-01 2023-03-31 09364585 bus:Director1 1 2022-04-01 2023-03-31 09364585 bus:Director2 2022-04-01 2023-03-31 09364585 bus:Director2 1 2022-04-01 2023-03-31 09364585 bus:Director3 2022-04-01 2023-03-31 09364585 bus:Director3 1 2022-04-01 2023-03-31 09364585 bus:OrdinaryShareClass1 bus:CumulativeShares 2022-04-01 2023-03-31 09364585 bus:OrdinaryShareClass2 bus:CumulativeShares 2022-04-01 2023-03-31 09364585 bus:OrdinaryShareClass3 bus:CumulativeShares 2022-04-01 2023-03-31 09364585 bus:OrdinaryShareClass4 bus:CumulativeShares 2022-04-01 2023-03-31 09364585 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 09364585 core:Goodwill 2022-04-01 2023-03-31 09364585 core:ComputerEquipment 2022-04-01 2023-03-31 09364585 core:FurnitureFittings 2022-04-01 2023-03-31 09364585 core:OfficeEquipment 2022-04-01 2023-03-31 09364585 core:PlantMachinery 2022-04-01 2023-03-31 09364585 core:KeyManagementPersonnelCloseFamilyMembersEntitiesUnderKeyManagementPersonnelsControl 2022-04-01 2023-03-31 09364585 countries:EnglandWales 2022-04-01 2023-03-31 09364585 2022-03-31 09364585 bus:Director1 1 2022-03-31 09364585 bus:Director2 1 2022-03-31 09364585 bus:Director3 1 2022-03-31 09364585 core:Goodwill 2022-03-31 09364585 core:FurnitureFittings 2022-03-31 09364585 core:OfficeEquipment 2022-03-31 09364585 core:PlantMachinery 2022-03-31 09364585 2021-04-01 2022-03-31 09364585 2022-03-31 09364585 bus:Director1 1 2022-03-31 09364585 bus:Director2 1 2022-03-31 09364585 bus:Director3 1 2022-03-31 09364585 bus:OrdinaryShareClass1 bus:CumulativeShares 2022-03-31 09364585 bus:OrdinaryShareClass2 bus:CumulativeShares 2022-03-31 09364585 bus:OrdinaryShareClass3 bus:CumulativeShares 2022-03-31 09364585 bus:OrdinaryShareClass4 bus:CumulativeShares 2022-03-31 09364585 core:AcceleratedTaxDepreciationDeferredTax 2022-03-31 09364585 core:CapitalRedemptionReserve 2022-03-31 09364585 core:RetainedEarningsAccumulatedLosses 2022-03-31 09364585 core:ShareCapital 2022-03-31 09364585 core:CurrentFinancialInstruments core:WithinOneYear 2022-03-31 09364585 core:Goodwill 2022-03-31 09364585 core:FurnitureFittings 2022-03-31 09364585 core:OfficeEquipment 2022-03-31 09364585 core:PlantMachinery 2022-03-31 09364585 bus:Director1 1 2021-04-01 2022-03-31 09364585 bus:Director2 1 2021-04-01 2022-03-31 09364585 bus:Director3 1 2021-04-01 2022-03-31 09364585 bus:Director1 1 2021-03-31 09364585 bus:Director2 1 2021-03-31 09364585 bus:Director3 1 2021-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09364585

Prepared for the registrar

Eye Veterinary Clinic Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 31 March 2023

 

Eye Veterinary Clinic Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 10

 

Eye Veterinary Clinic Limited

Company Information

Directors

C L Heinrich

K P Walsh

R A Grundon

Registered office

The Veterinary Eye Hospital
Marlbrook
Leominster
Herefordshire
HR6 0PH

Accountants

Hazlewoods LLP
Staverton Court
Staverton
Cheltenham
GL51 0UX

 

Eye Veterinary Clinic Limited

(Registration number: 09364585)
Balance Sheet as at 31 March 2023

Note

2023
 £

2022
 £

Fixed assets

 

Intangible assets

4

-

16,469

Tangible assets

5

302,085

228,950

 

302,085

245,419

Current assets

 

Stocks

42,479

32,435

Debtors

6

103,540

85,252

Cash at bank and in hand

 

1,049,909

933,661

 

1,195,928

1,051,348

Creditors: Amounts falling due within one year

7

(284,714)

(275,254)

Net current assets

 

911,214

776,094

Total assets less current liabilities

 

1,213,299

1,021,513

Deferred tax liabilities

8

(73,380)

(56,846)

Net assets

 

1,139,919

964,667

Capital and reserves

 

Called up share capital

9

185

185

Capital redemption reserve

15

15

Profit and loss account

1,139,719

964,467

Total equity

 

1,139,919

964,667

For the financial year ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

 

Eye Veterinary Clinic Limited

(Registration number: 09364585)
Balance Sheet as at 31 March 2023

Approved and authorised by the Board on 2 November 2023 and signed on its behalf by:
 


C L Heinrich
Director


K P Walsh
Director


R A Grundon
Director

 

Eye Veterinary Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
The Veterinary Eye Hospital
Marlbrook
Leominster
Herefordshire
HR6 0PH
England

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's current forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

 

Eye Veterinary Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Government grants

Government grants are recognised based on the accrual model and are measured at the fair value of the asset received or receivable. Grants are classified as relating either to revenue or to assets. Grants relating to revenue are recognised in income over the period in which the related costs are recognised. Grants relating to assets are recognised over the expected useful life of the asset. Where part of a grant relating to an asset is deferred, it is recognised as deferred income.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

 

Eye Veterinary Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

10% of written down value

Fixtures and fittings

15% of written down value

Office equipment

15% of written down value

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

12.5% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

 

Eye Veterinary Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

 

Eye Veterinary Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

 

4

Intangible assets

Goodwill
 £

Total
£

Cost

At 1 April 2022

131,745

131,745

At 31 March 2023

131,745

131,745

Amortisation

At 1 April 2022

115,276

115,276

Amortisation charge

16,469

16,469

At 31 March 2023

131,745

131,745

Carrying amount

At 31 March 2023

-

-

At 31 March 2022

16,469

16,469

 

5

Tangible assets

Fixtures and fittings
£

Plant and machinery
£

Office equipment
£

Total
£

Cost or valuation

At 1 April 2022

38,640

292,019

52,898

383,557

Additions

31,034

68,187

7,645

106,866

At 31 March 2023

69,674

360,206

60,543

490,423

Depreciation

At 1 April 2022

18,982

111,501

24,124

154,607

Charge for the year

6,422

21,361

5,948

33,731

At 31 March 2023

25,404

132,862

30,072

188,338

Carrying amount

At 31 March 2023

44,270

227,344

30,471

302,085

At 31 March 2022

19,658

180,518

28,774

228,950

 

6

Debtors

2023
 £

2022
 £

Trade debtors

70,901

61,610

Other debtors

3,614

6,002

Prepayments

29,025

17,640

 

103,540

85,252

 

Eye Veterinary Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

 

7

Creditors

Note

2023
 £

2022
 £

Due within one year

 

Trade creditors

 

48,808

49,589

Social security and other taxes

 

220,199

214,798

Outstanding defined contribution pension costs

 

6,419

-

Other creditors

 

1,835

4,404

Accrued expenses

 

7,453

6,463

 

284,714

275,254

 

8

Deferred tax

Deferred tax assets and liabilities

2023

Liability
£

Difference between depreciation and amortisation and capital allowances

74,318

Short term timing differences

(938)

73,380

2022

Liability
£

Difference between depreciation and amortisation and capital allowances

56,846

56,846

 

9

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary A shares of £1 each

32

32

32

32

Ordinary B shares of £1 each

31

31

31

31

Ordinary C shares of £1 each

32

32

32

32

Ordinary D shares of £1 each

90

90

90

90

 

185

185

185

185

The different classes of shares referred to above carry separate rights to dividends but, in all other significant aspects, rank pari passu.

 

Eye Veterinary Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 March 2023

 

10

Related party transactions

Summary of transactions with key management

Key management personnel are considered to be the directors of the company.

The overdrawn loans are included in other debtors and are analysed in the table below.

 

Transactions with directors

2023

At 1 April 2022
£

Advances to director
£

Repayments by director
£

At 31 March 2023
£

C L Heinrich

Amounts due to/(from) director

(1,710)

(87,572)

88,212

(1,070)

         
       

K P Walsh

Amounts due to/(from) director

(1,985)

(87,572)

88,212

(1,345)

         
       

R A Grundon

Amounts due to/(from) director

(2,307)

(87,104)

88,212

(1,199)

         
       

 

2022

At 1 April 2021
£

Advances to director
£

Repayments by director
£

At 31 March 2022
£

C L Heinrich

Amounts due to/(from) director

(516)

(87,674)

86,480

(1,710)

         
       

K P Walsh

Amounts due to/(from) director

(731)

(87,734)

86,480

(1,985)

         
       

R A Grundon

Amounts due to/(from) director

(1,605)

(87,182)

86,480

(2,307)